Roche Holding AG (RHHBY)
50.23
-0.32
(-0.63%)
USD |
OTCM |
Jun 09, 16:00
Roche Price : 50.23 for June 9, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jun 09, 2026 | 50.08 | 50.40 | 49.47 | 50.23 | 1.238M |
| Jun 08, 2026 | 50.78 | 51.04 | 50.31 | 50.55 | 3.354M |
| Jun 05, 2026 | 51.49 | 51.72 | 51.02 | 51.48 | 2.067M |
| Jun 04, 2026 | 51.11 | 51.84 | 51.11 | 51.57 | 1.451M |
| Jun 03, 2026 | 48.84 | 49.28 | 48.83 | 49.00 | 1.914M |
| Jun 02, 2026 | 49.27 | 49.36 | 48.10 | 49.07 | 1.687M |
| Jun 01, 2026 | 51.28 | 51.38 | 50.06 | 50.22 | 3.411M |
| May 29, 2026 | 52.84 | 52.97 | 52.36 | 52.40 | 687526.0 |
| May 28, 2026 | 51.73 | 52.52 | 51.69 | 52.36 | 1.747M |
| May 27, 2026 | 52.21 | 52.68 | 52.07 | 52.47 | 673263.0 |
| May 26, 2026 | 53.10 | 53.13 | 52.43 | 52.60 | 1.375M |
| May 22, 2026 | 52.93 | 53.54 | 52.83 | 53.34 | 1.358M |
| May 21, 2026 | 51.85 | 53.20 | 51.60 | 52.71 | 784585.0 |
| May 20, 2026 | 51.75 | 52.56 | 51.75 | 51.94 | 2.983M |
| May 19, 2026 | 51.70 | 52.38 | 51.61 | 51.86 | 5.423M |
| May 18, 2026 | 50.99 | 51.36 | 50.81 | 51.10 | 3.680M |
| May 15, 2026 | 51.79 | 51.95 | 50.96 | 51.09 | 1.123M |
| May 14, 2026 | 51.00 | 51.80 | 51.00 | 51.29 | 1.194M |
| May 13, 2026 | 50.77 | 51.36 | 50.71 | 51.26 | 7.855M |
| May 12, 2026 | 51.12 | 51.61 | 51.01 | 51.18 | 10.79M |
| May 11, 2026 | 51.16 | 51.60 | 51.09 | 51.41 | 3.332M |
| May 08, 2026 | 50.75 | 51.09 | 50.41 | 51.09 | 1.507M |
| May 07, 2026 | 51.88 | 51.92 | 50.33 | 50.58 | 785394.0 |
| May 06, 2026 | 51.75 | 51.90 | 51.41 | 51.63 | 2.640M |
| May 05, 2026 | 51.09 | 51.10 | 50.63 | 50.84 | 671626.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Novartis AG | 148.14 |
| Eli Lilly & Co. | 1136.26 |
| Pfizer Inc. | 25.61 |
| GSK Plc | 51.19 |
| Johnson & Johnson | 238.52 |
Price Related Metrics
| PE Ratio | 20.91 |
| PS Ratio | 4.354 |
| PEG Ratio | 0.9863 |
| Price to Free Cash Flow | 21.41 |
| Earnings Yield | 4.78% |
| PEGY Ratio | 0.861 |
| Operating PE Ratio | 14.17 |
| Normalized PE Ratio | 17.93 |